Showing 1851-1860 of 3223 results for "".
- Alimera Completes Recruitment for Its NEW DAY Study Evaluating Iluvien for DMEhttps://modernod.com/news/alimera-completes-recruitment-for-its-landmark-new-day-study/2481633/Alimera Sciences announced that it has completed enrollment for the company’s NEW DAY clinical trial, a randomized, controlled, multicenter study designed to generate prospective data for Iluvien (fluocinolone acetonide intravitreal implant, 0.19mg) as a baseline therapy in p
- Alimera Acquires US Commercial Rights to Yutiqhttps://modernod.com/news/alimera-acquires-us-commercial-rights-to-yutiq/2481624/Alimera Sciences has acquired additional commercialization rights for Yutiq (fluocinolone acetonide intravitreal insert, 0.18mg) for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye from EyePoint Pharmaceuticals. Alimera now has exclusi
- Alcon Expands Plastic Bank Partnership in 2023 to Further Support Sustainability Effortshttps://modernod.com/news/alcon-expands-plastic-bank-partnership-in-2023-to-further-support-sustainability-efforts/2481591/Alcon announced the expansion of the partnership with Plastic Bank—an organization that builds recycling ecosystems in under-developed communities to fight plastic pollution while providing collection members with a path out of poverty. For each ton of plastic introduced in the marketp
- Alcon Announces its Largest Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivityhttps://modernod.com/news/alcon-announces-its-largest-scientific-presence-at-ascrs-2023-and-expands-image-guided-connectivity/2481588/Alcon announced its surgical ophthalmic presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2023 annual meeting, taking place May 5-8 in San Diego, and stated that its innovations will be featured in more studies than ever in its history.[1] Alcon ASCRS even
- Alcon Names Daniel M. Miller, MD, PhD, Senior Scientific Advisor to Alcon's R&D team PDFhttps://modernod.com/news/alcon-names-daniel-m-miller-md-phd-senior-scientific-advisor-to-alcons-rd-team-pdf/2481584/Alcon announced that the highly esteemed ophthalmologist, Daniel M. Miller, MD, PhD, will join Alcon as a member of the Research and Development (R&D) team. Dr. Miller is a fellowship-trained medical and surgical retina specialist. He will serve as a Senior Scientific Advisor to Alc
- Johnson & Johnson Vision Receives FDA Clearance for its Elita Femtosecond Laserhttps://modernod.com/news/johnson-johnson-vision-receives-fda-clearance-for-its-elita-femtosecond-laser/2481573/Johnson & Johnson Vision announced that it has received FDA 510(k) clearance for the Elita Femtosecond Laser for the creation of LASIK flaps. Elita will be unveiled at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in San Diego, May 5-8
- Allegro Ophthalmics Receives Approval from FDA for Design of Phase 2b/3 Clinical Trial of Risuteganib for the Treatment of Intermediate Dry AMDhttps://modernod.com/news/allegro-ophthalmics-receives-approval-from-fda-for-design-of-phase-2b3-clinical-trial-of-risuteganib-for-the-treatment-of-intermediate-dry-amd/2481527/Allegro Ophthalmics announced that the company has received agreement from the FDA under a Special Protocol Assessment (SPA) for the design of its phase 2b/3 clinical trial of risuteganib (Luminate) for the treatment of intermediate, dry age-related macular degeneration (AMD).
- Sight Sciences Appoints Ali Bauerlein as Chief Financial Officerhttps://modernod.com/news/sight-sciences-appoints-ali-bauerlein-as-chief-financial-officer/2481509/Sight Sciences announced the appointment of Alison “Ali” Bauerlein as its Chief Financial Officer and Treasurer, effective April 3, 2023. “I am incredibly excited to have Ali join Sight Sciences as we scale our business and drive toward profitable growth
- World Council of Optometry and Alcon to Launch “WCO Alcon Dry Eye Wheel” Tool for Dry Eye Diseasehttps://modernod.com/news/world-council-of-optometry-and-alcon-to-launch-wco-alcon-dry-eye-wheel-tool-for-dry-eye-disease/2481496/The World Council of Optometry (WCO) and Alcon invite eye care professionals worldwide to the launch of a new tool to help with the diagnosis and treatment of dry eye disease. Registration is now open for the May 9 “Dry Eye Spotlight 4: WCO Alcon Dry Eye Wheel” webinar, the
- BioCareSD and AllyRetina GPO Partner to Help Retina Providers Improve Patient Care and Increase Efficiencyhttps://modernod.com/news/biocaresd-and-allyretina-gpo-partnership-to-help-retina-providers-improve-patient-care-and-increase-efficiency/2481473/BioCareSD announced its partnership with AllyRetina. Debuting at the American Society of Retina Specialists (ASRS) 24th Annual Business of Retina conference this week, AllyRetina will serve its GPO members through its physician leadership, a seasoned management team, and innovative tools and